COVID: CDC vaccine advisers to revisit benefits and risks of Johnson & Johnson vaccine
COVID: CDC vaccine advisers to revisit benefits and risks of Johnson & Johnson vaccine
By Jamie Gumbrecht and Elizabeth Cohen, CNN
(CNN) — The US Centers for Disease Control and Prevention’s vaccine advisers will meet on Thursday to revisit the benefits and risks for the Johnson & Johnson Covid-19 vaccine.
The Advisory Committee on Immunization Practices is scheduled to vote on “updated recommendations for use,” according to an agenda for the meeting posted online Wednesday.
The…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.